The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Association of tumor-infiltrating lymphocytes (TILs) and immune signatures with PAM50 intrinsic subtyping hormone receptor-positive (HR+)/HER2-negative (HER2-) early breast cancer (BC): A translational analysis of two multicentric neoadjuvant trials.
 
Gaia Griguolo
Consulting or Advisory Role - Gilead Sciences; Menarini; Seagen
Speakers' Bureau - Lilly; MSD
Travel, Accommodations, Expenses - Amgen; Daiichi Sankyo/Astra Zeneca; Gilead Sciences; Lilly; Novartis; Pfizer
 
Laia Paré
Employment - Reveal Genomics
 
Federica Miglietta
Consulting or Advisory Role - AstraZeneca; MSD
Speakers' Bureau - Gilead Sciences; Novartis; Pfizer; Seagen
Travel, Accommodations, Expenses - Gilead Sciences; Novartis
 
Michele Bottosso
No Relationships to Disclose
 
Daniele Giulio Generali
No Relationships to Disclose
 
Antonio Frassoldati
Employment - Lilly
Consulting or Advisory Role - Daiichi Sankyo/Astra Zeneca; Gilead Sciences; Novartis; Seagen
Travel, Accommodations, Expenses - Novartis
 
Antonino Musolino
Consulting or Advisory Role - Daiichi Sankyo/Astra Zeneca; Eisai Europe; Lilly; Seagen
Research Funding - Lilly; Roche (Inst)
Travel, Accommodations, Expenses - Pfizer
 
Simon Spazzapan
Honoraria - AstraZeneca; Lilly; MSD; Mundipharma; Novartis; Pfizer; Seagen
Consulting or Advisory Role - AstraZeneca; MSD; Seagen
 
Grazia Vernaci
No Relationships to Disclose
 
Tommaso Giarratano
Honoraria - Daiichi Sankyo; Lilly; Novartis; Roche; Seagen
 
Rocco Cappellesso
No Relationships to Disclose
 
Giancarlo Bisagni
No Relationships to Disclose
 
Federico Piacentini
Consulting or Advisory Role - Roche; Seagen
Expert Testimony - Gilead Sciences
Travel, Accommodations, Expenses - AstraZeneca/Daiichi Sankyo; GENTILI; Lilly; Novartis
Other Relationship - Pfizer
 
Enrico Tagliafico
Consulting or Advisory Role - MSD
 
Katia Cagossi
No Relationships to Disclose
 
Claudia Pinato
No Relationships to Disclose
 
Francesca Schiavi
No Relationships to Disclose
 
Aleix Prat
Employment - Reveal Genomics
Leadership - Reveal Genomics
Stock and Other Ownership Interests - Reveal Genomics
Honoraria - AstraZeneca; Daiichi Sankyo; Novartis; Pfizer; Roche
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo; Novartis; Oncolytics; Pfizer; Roche
Research Funding - AstraZeneca; Daiichi Sankyo; Novartis (Inst); Roche (Inst)
Patents, Royalties, Other Intellectual Property - HER2DX filing; METHODS FOR BREAST CANCER TREATMENT AND PREDICTION OF THERAPEUTIC RESPONSE (US 63/023785); PCT/EP2016/080056: HER2 AS A PREDICTOR OF RESPONSE TO DUAL HER2 BLOCKADE IN THE ABSENCE OF CYTOTOXIC THERAPY; TNBC-DX
Travel, Accommodations, Expenses - Daiichi Sankyo
Other Relationship - Oncolytics; Peptomyc
 
Maria Vittoria Dieci
Consulting or Advisory Role - Daiichi Sankyo; Exact Sciences; Gilead Sciences; Lilly; MSD; Novartis; Pfizer; Roche; Seagen
Patents, Royalties, Other Intellectual Property - Patent pending HER2DX licensed to University of Padova
 
Valentina Guarneri
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo; Eisai; Exact Sciences; Gilead Sciences; Lilly; Merck Serono; MSD; Novartis; Olema Oncology; Pierre Fabre
Speakers' Bureau - AstraZeneca; Daiichi Sankyo; Gilead Sciences; GlaxoSmithKline; Lilly; Menarini Steamline; Novartis; Roche; Zentiva
Research Funding - AstraZeneca (Inst); BMS (Inst); Daiichi Sankyo/Astra Zeneca (Inst); GlaxoSmithKline (Inst); Lilly (Inst); Merck (Inst); Merck KGaA (Inst); Nerviano Medical Sciences (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst); Seagen (Inst); Synthon (Inst)
Expert Testimony - Lilly
Travel, Accommodations, Expenses - AstraZeneca; Gilead/Forty Seven